Drug resistance among tuberculosis patients attending diagnostic and treatment centres in Makassar, Indonesia

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 4, 2011, Pages 489-495

  Massi, Muh Nasrum ^a   Wahyuni, S ^a   Halik, H ^a   Anita, ^a   Yusuf, I ^a   Leong, F J ^b   Dick, T ^b   Phyu, S ^b  

^a HASANUDDIN UNIVERSITY   (Indonesia)

^b NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

Author keywords

Drug resistant TB; Indonesia; Makassar; MDR TB; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEMOPTYSIS; HUMAN; INDONESIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RELAPSE; RISK ASSESSMENT; RISK FACTOR; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; URBAN AREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INDONESIA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 79952781485     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.09.0730     Document Type: Article

References (28)

1. Ministry of Health Republic of Indonesia/World Health Organization. TB fact sheet. Jakarta, Indonesia: Directorate General of Disease Control and Prevention and Health Environment, 2008. www.tbindonesia.or.id/pdf/TB-Fact- Sheet.pdf Accessed January 2011.
2. World Health Organization. WHO report 2009. Global TB control 2009: epidemiology, strategy, financing. WHO/HTM/TB/ 2009.411. Geneva, Switzerland: WHO, 2009: pp 113-116.
3. Departemen Kesehatan Republik Indonesia. Pengobatan Penderita. In: Pedoman Nasional Penganggulangan Tuberkulosis, Departemen Kesehatan, VIII ed. Jakarta, Indonesia: Departemen Kesehatan Republik Indonesia, 2002: pp 13-15. [Indonesian]
4. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 4th ed. WHO/HTM/TB/2009. 420. Geneva, Switzerland: WHO, 2009.
5. World Health Organization. Guidance on regulations for the transport of infectious substances, 2007-2008. WHO/CDS/EPR/ 2007.2. Geneva, Switzerland: WHO, 2007.
6. Vandepitte J, Verhaegen J, Engbaek K, Rohner P, Piot P, Heuck C C. Basic laboratory procedures in clinical bacteriology. 2nd ed. Geneva, Switzerland: WHO, 2003: pp 83.
7. Siddiqi S H, Rüsch-Gerdes S. MGITTM procedure manual: Mycobacteria Growth Indicator Tube (MGIT) culture and drug susceptibility demonstration projects. Geneva, Switzerland: Foundation for Innovative New Diagnostics, 2006.
8. World Health Organization. Laboratory services in tuberculosis control. Part II. Microscopy. WHO/TB/98.258. Geneva, Switzerland: WHO, 1998.
9. Phyu S, Lwin T, Ti T, et al. Drug-resistant tuberculosis in Yangon, Myanmar. Scand J Infect Dis 2005; 37: 846-851.
10. World Health Organization. Anti-tuberculosis drug resistance in the world. Report no 4. WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
11. Kelly P M, Ardian M, Waramori G. A community-based TB drug susceptibility study in Mimika District, Papua Province, Indonesia. Int J Tuberc Lung Dis 2006; 10: 167-171. (Pubitemid 43275540)
12. Rivera A B, Tupasi T E, Balagtas E D, et al. Drug-resistant tuberculosis in the Philippines. Int J Tuberc Lung Dis 1999; 3: 639.
13. Huong N T, Lan N T, Cobelens F G, et al. Anti-tuberculosis drug resistance in the south of Vietnam: prevalence and trends. J Infect Dis 2006; 194: 1226-1232. (Pubitemid 44630967)
14. Ohkado A, Aguiman L, Adlawan S, et al. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines. Int J Tuberc Lung Dis 2006; 10: 283-289.
15. Hu Y, Hoffner S, Jiang W, Wang W, Xu B. Extensive transmission of isoniazid-resistant M. tuberculosis and its association with increased multidrug-resistant TB in 2 rural countries of eastern China: a molecular epidemiological study. BMC Infect Dis 2010; 10: 43.
16. Lew W, Pai M, Oxlade O, et al. Initial drug resistance and tuberculosis treatment outcomes: systematic review and metaanalysis. Ann Intern Med 2008; 149: 123-134. (Pubitemid 352008599)
17. Quy H T, Lan N T N, Borgdorff M W, et al. Drug resistance among failure and relapse cases of tuberculosis: is the standard retreatment regimen adequate? Int J Tuberc Lung Dis 2003; 7: 631-636.
18. Abate G, Miörner H, Ahmed O, Hoffner S E. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs. Int J Tuberc Lung Dis 1998; 2: 580-584.
19. Chonde T M, Basra D, Mfinanga S G M, et al. National anti-tuberculosis drug resistance study in Tanzania. Int J Tuberc Lung Dis 2010; 14: 967-972.
20. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Critic Care Med 2000; 161: 1376-1375.
21. Shimao T. Drug resistance in tuberculosis control. Tubercle 1987; 68: 5-18.
22. Espinal M A. Time to abandon the standard retreatment regimen with first-line drugs for failures of standard treatment. Int J Tuberc Lung Dis 2003; 7: 607-608. (Pubitemid 36806852)
23. Toungoussova O S, Nizovtseva N I, Mariandyshev A O, Caugant D A, Sandven P, Bjune G. Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999. Eur J Clin Microbiol Infect Dis 2004; 23: 174-179.
24. Suárez P G, Floyd K, Portocarrero J, et al. Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet 2002; 359: 1980-1989. (Pubitemid 34663712)
25. Fleming M F, Krupitsky E, Tsoy M, et al. Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. Int J Tuberc Lung Dis 2006; 10: 565-570. (Pubitemid 43667647)
26. Shin S S, Pasechnikov A D, Gelmanova I Y, et al. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis 2006; 10: 402-408.
27. Joseph B V, Soman S, Radhakrishnan I, et al. Drug resistance in Mycobacterium tuberculosis isolates from tuberculosis patients in Kerala, India. Int J Tuberc Lung Dis 2009; 13: 494-499.
28. American Thoracic Society. Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156 (2 Pt 2): S1-S25.